The information on these pages is restricted and must be viewed by UK Healthcare Professionals only

Octasa® (mesalazine)

Octasa® 400mg and 800mg modified release tablets (mesalazine)
Octasa 400mg and 800mg modified-release tablets are indicated in adults, children and adolescents above 6 years for:

Ulcerative colitis:

  • For the treatment of mild to moderate acute exacerbations. For the maintenance of remission.

Crohn’s ileo-colitis:

  • For the maintenance of remission

 

Octasa 400mg SPC: https://www.medicines.org.uk/emc/product/2827/smpc

Octasa 800mg SPC: https://www.medicines.org.uk/emc/product/4479/smpc

 

Octasa® 1600mg modified release tablets (mesalazine)
Octasa 1600 mg modified-release tablets are indicated in adults for:

Ulcerative colitis:

  • For the treatment of mild to moderate acute disease. For the maintenance of remission.

 

Octasa 1600mg SPC: https://www.medicines.org.uk/emc/product/10803/smpc

 

Octasa® 1g suppositories
Octasa suppositories are indicated in adults for:

Ulcerative proctitis:

  • Treatment of acute mild to moderate ulcerative proctitis.
  • Maintenance of remission of ulcerative proctitis.

 

Octasa 1g suppositories SPC: https://www.medicines.org.uk/emc/product/12469/smpc

 

Tillotts endeavour to always have sufficient stock to meet demand.

If you are having difficulty obtaining any of Tillotts medicines or if you would like further information please contact: enquiries@tillotts.com

NU-01236 June 2021

Octasa® (mesalazine)

You are about to leave tillotts.co.uk for an external website. Tillotts is not responsible for the content of other websites.

Go back
WordPress Image Lightbox